ClearPoint Neuro, Inc.
CLPTNasdaqCIK 1285550HealthcareFiscal year ends Dec 31
Reports and events: 321 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2817:25 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-436412 |
| 2026-10-2816:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436125 |
| 2026-08-0317:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-330842 |
| 2026-08-0316:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-330541 |
| 2026-05-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-234571 |
| 2026-05-1317:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221890 |
| 2026-05-1316:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-221596 |
| 2026-04-1016:30 ET | DEF 14A | Proxy statementPeriod 2026-04-10 | 0001193125-26-151345 |
| 2026-03-1717:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-111231 |
| 2026-03-1716:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-110780 |
| 2026-02-0516:25 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-26-039470 |
| 2026-01-1208:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009867 |
| 2026-01-0508:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-001581 |
| 2025-11-2017:08 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-290003 |
| 2025-11-0617:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-270123 |
| 2025-11-0616:57 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-270019 |
| 2025-11-0616:52 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-269992 |
| 2025-08-1217:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001285550-25-000012 |
| 2025-08-1216:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-25-000010 |
| 2025-06-1716:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-004550 |
| 2025-05-2316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-076992 |
| 2025-05-1916:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-074397 |
| 2025-05-1317:24 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070545 |
| 2025-05-1316:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-070346 |
| 2025-05-1216:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-069175 |
| 2025-04-0916:22 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0000950170-25-052528 |
| 2025-02-2617:17 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027934 |
| 2025-02-2616:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-027716 |
| 2024-11-0717:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-115372 |
| 2024-11-0716:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001285550-24-000121 |
| 2024-11-0716:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000120 |
| 2024-08-2616:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000107 |
| 2024-08-0717:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001285550-24-000098 |
| 2024-08-0716:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000097 |
| 2024-05-1606:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001285550-24-000061 |
| 2024-05-0717:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001285550-24-000051 |
| 2024-05-0716:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000049 |
| 2024-04-0516:34 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001285550-24-000045 |
| 2024-03-1217:17 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001285550-24-000031 |
| 2024-03-1216:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000030 |
| 2024-03-0116:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-029960 |
| 2024-01-0816:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000016 |
| 2023-11-0917:09 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001285550-23-000115 |
| 2023-11-0916:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-23-000114 |
| 2023-08-0817:25 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001285550-23-000097 |
| 2023-08-0816:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-23-000096 |
| 2023-08-0116:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001285550-23-000091 |
| 2023-05-2516:23 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001285550-23-000050 |
| 2023-05-2217:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001285550-23-000048 |
| 2023-05-1117:17 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001285550-23-000046 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 05:15 ET. Listed shows no prices and gives no investment advice.